Concepts (239)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- Acute Disease
- Acute Kidney Injury
- Adenine
- Adenosine Monophosphate
- Administration, Oral
- Adolescent
- Adult
- Age Factors
- Aged
- Aged, 80 and over
- Aging
- Alanine
- Alanine Transaminase
- Algorithms
- Alkynes
- Ambulatory Care
- Aminoglycosides
- Anemia
- Animals
- Anti-Bacterial Agents
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Antibodies, Neutralizing
- Antibodies, Viral
- Antidepressive Agents
- Anti-HIV Agents
- Anti-Inflammatory Agents
- Antimalarials
- Antiretroviral Therapy, Highly Active
- Antirheumatic Agents
- Antitoxins
- Antiviral Agents
- Anus Neoplasms
- Area Under Curve
- Autoimmune Diseases
- Bacterial Proteins
- Benzoxazines
- Betacoronavirus
- beta-Lactamases
- Bone Density
- Carbapenems
- Carrier State
- Case-Control Studies
- CCR5 Receptor Antagonists
- CD4 Lymphocyte Count
- CD4-CD8 Ratio
- Cell Culture Techniques
- Child
- China
- Cholesterol, HDL
- Cholesterol, LDL
- Clostridium Infections
- Cobicistat
- Cohort Studies
- Colistin
- Combined Modality Therapy
- Communicable Diseases, Emerging
- Communicable Diseases, Imported
- Comorbidity
- Compassionate Use Trials
- Complement C3
- Complement C4
- Computational Biology
- Coronavirus
- Coronavirus Infections
- Cost Savings
- Cost-Benefit Analysis
- Critical Pathways
- Cross-Sectional Studies
- Cryoglobulinemia
- Cryoglobulins
- Cyclohexanes
- Cyclopropanes
- Cytochrome P-450 CYP3A Inhibitors
- Cytokines
- Darunavir
- Delphi Technique
- Depression
- Developing Countries
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Disease Outbreaks
- Disease Progression
- Drug Combinations
- Drug Costs
- Drug Interactions
- Drug Resistance, Bacterial
- Drug Resistance, Viral
- Drug Substitution
- Drug Therapy, Combination
- Drugs, Generic
- Emigrants and Immigrants
- Emtricitabine
- Equilibrative Nucleoside Transporter 1
- Europe
- Expert Testimony
- Female
- Fever
- Fluoroquinolones
- Follow-Up Studies
- Gastrointestinal Diseases
- Genome, Bacterial
- Genome, Viral
- Genomics
- Genotype
- Global Health
- Glomerulonephritis
- Glycated Hemoglobin A
- Guidelines as Topic
- Hair
- Health Plan Implementation
- Health Services Accessibility
- Hemoglobins
- Henipavirus Infections
- Hepacivirus
- Hepatitis C
- Hepatitis C, Chronic
- Heterocyclic Compounds, 3-Ring
- HIV
- HIV Fusion Inhibitors
| - HIV Infections
- HIV Integrase Inhibitors
- HIV Protease Inhibitors
- HIV-1
- Hospitalization
- Hospitals
- Humans
- Hydrogen Peroxide
- Hydroxychloroquine
- Hyperlactatemia
- Hypoglycemic Agents
- Immune System Diseases
- Immunoglobulin G
- Immunosuppressive Agents
- Incidence
- Infection Control
- Inflammation
- Inflammatory Bowel Diseases
- Intensive Care Units
- Interferons
- Italy
- Kaplan-Meier Estimate
- Kinetics
- Klebsiella Infections
- Klebsiella pneumoniae
- Lamivudine
- Longevity
- Lopinavir
- Lost to Follow-Up
- Lung Diseases
- Lymphocyte Count
- Malaria
- Male
- Mass Screening
- Medication Adherence
- Metformin
- Middle Aged
- Middle East Respiratory Syndrome Coronavirus
- Multilocus Sequence Typing
- Multiple Myeloma
- Mutation
- Nasopharynx
- Nipah Virus
- Oligopeptides
- Oxazines
- Oxidants
- Pandemics
- Papillomaviridae
- Patient Compliance
- Patient Discharge
- Phylogeny
- Piperazines
- Placebos
- Pneumonia
- Pneumonia, Viral
- Polymorphism, Single Nucleotide
- Pre-Exposure Prophylaxis
- Preliminary Data
- Prescriptions
- Prevalence
- Primates
- Proline
- Proportional Hazards Models
- Prospective Studies
- Protease Inhibitors
- Psychotropic Drugs
- Pyridones
- Pyrophosphatases
- Quality of Life
- Quinolones
- Radiography, Thoracic
- Raltegravir Potassium
- Randomized Controlled Trials as Topic
- Real-Time Polymerase Chain Reaction
- Receptors, Interleukin-6
- Recurrence
- Regression Analysis
- Reproducibility of Results
- Respiration, Artificial
- Respiratory Insufficiency
- Retrospective Studies
- Rheumatic Diseases
- Ribavirin
- Rilpivirine
- Risk Factors
- Ritonavir
- RNA, Messenger
- RNA, Viral
- Salvage Therapy
- Self Report
- Sequence Analysis, DNA
- Seroconversion
- Severe Acute Respiratory Syndrome
- Simeprevir
- Skin Diseases
- Skin Diseases, Bacterial
- Sofosbuvir
- Spike Glycoprotein, Coronavirus
- Sustained Virologic Response
- Tablets
- Taste Disorders
- Tenofovir
- Therapeutic Equivalency
- Time Factors
- Transaminases
- Travel
- Treatment Failure
- Treatment Outcome
- Triazoles
- United States
- United States Food and Drug Administration
- Uveitis
- Vaccination
- Viral Load
- Viral Nonstructural Proteins
- Virus Shedding
- Whole Genome Sequencing
- World Health Organization
- Young Adult
|
Rizzardini's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(239)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(204)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_